Actinium Pharmaceuticals $ATNM: A Hidden Gem in the Biotech Sector

Celator Pharmaceuticals Inc. (NASDAQ: CPXX) has been one of the biggest gainers in the biotech sector this year. Year-to-date, CPXX has gained more than 1600%. Some of the gains have come recentlypaymentdatasystems-650x535 after the company agreed to be acquired by Jazz Pharmaceuticals (NASDAQ: JAZZ). But even before the acquisition news came, CPXX had logged in substantial gains. The reason behind the rally in CPXX has been positive top-line results from its Phase 3 clinical trial evaluating its lead product candidate VYXEOS(TM) in patients with high-risk (secondary) acute myeloid leukemia (AML) compared to the standard of care. The question is whether there is any other opportunity like CPXX in the market right now.Read more